Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

C4B antibody

This anti-C4B antibody is a Mouse Monoclonal antibody detecting C4B in IHC, IF and StM. Suitable for Human.
Catalog No. ABIN6940809

Quick Overview for C4B antibody (ABIN6940809)

Target

See all C4B (C4b) Antibodies
C4B (C4b) (Complement Component C4b (C4b))

Reactivity

  • 54
  • 23
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 63
  • 9
  • 3
Mouse

Clonality

  • 66
  • 9
Monoclonal

Conjugate

  • 32
  • 9
  • 8
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This C4B antibody is un-conjugated

Application

  • 42
  • 29
  • 20
  • 18
  • 13
  • 13
  • 12
  • 7
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 1
Immunohistochemistry (IHC), Immunofluorescence (IF), Staining Methods (StM)

Clone

SPM545
  • Specificity

    This MAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d.C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 Molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

    Purification

    Purified by Protein A/G

    Immunogen

    Recombinant human Complement 4d protein

    Isotype

    IgG1 kappa
  • Application Notes

    Positive Control: Rejected Renal Transplant Tissue.

    Known Application: Immunofluorescence (1:50-1:100), Immunohistochemistry (Formalin-fixed) (1:200-1:400 for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 1 mM EDTA, pH 7.5-8.5, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-80 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Expiry Date

    24 months
  • Target

    C4B (C4b) (Complement Component C4b (C4b))

    Alternative Name

    C4B

    Molecular Weight

    192kDa (predicted)

    Gene ID

    720, 721

    Pathways

    Complement System
You are here:
Chat with us!